nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—arteriole—type 1 diabetes mellitus	0.0261	0.221	CbGeAlD
Zuclopenthixol—DRD1—nerve—type 1 diabetes mellitus	0.0162	0.136	CbGeAlD
Zuclopenthixol—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.0119	0.0305	CcSEcCtD
Zuclopenthixol—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.0114	0.0292	CcSEcCtD
Zuclopenthixol—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.0112	0.0945	CbGeAlD
Zuclopenthixol—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00961	0.0245	CcSEcCtD
Zuclopenthixol—DRD2—nerve—type 1 diabetes mellitus	0.00955	0.0806	CbGeAlD
Zuclopenthixol—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.0095	0.0802	CbGeAlD
Zuclopenthixol—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00895	0.0228	CcSEcCtD
Zuclopenthixol—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00885	0.0226	CcSEcCtD
Zuclopenthixol—Polyuria—Ramipril—type 1 diabetes mellitus	0.00818	0.0209	CcSEcCtD
Zuclopenthixol—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00808	0.0682	CbGeAlD
Zuclopenthixol—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00803	0.0205	CcSEcCtD
Zuclopenthixol—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00796	0.0203	CcSEcCtD
Zuclopenthixol—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00788	0.0201	CcSEcCtD
Zuclopenthixol—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00775	0.0198	CcSEcCtD
Zuclopenthixol—Amnesia—Ramipril—type 1 diabetes mellitus	0.00764	0.0195	CcSEcCtD
Zuclopenthixol—Purpura—Ramipril—type 1 diabetes mellitus	0.00745	0.019	CcSEcCtD
Zuclopenthixol—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00713	0.0182	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00663	0.0169	CcSEcCtD
Zuclopenthixol—Breast disorder—Ramipril—type 1 diabetes mellitus	0.00649	0.0166	CcSEcCtD
Zuclopenthixol—HTR2A—nerve—type 1 diabetes mellitus	0.0063	0.0532	CbGeAlD
Zuclopenthixol—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.00623	0.0526	CbGeAlD
Zuclopenthixol—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00615	0.0157	CcSEcCtD
Zuclopenthixol—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00605	0.0154	CcSEcCtD
Zuclopenthixol—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.0059	0.0151	CcSEcCtD
Zuclopenthixol—Neutropenia—Ramipril—type 1 diabetes mellitus	0.0058	0.0148	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00572	0.0146	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00567	0.0145	CcSEcCtD
Zuclopenthixol—Weight increased—Ramipril—type 1 diabetes mellitus	0.00565	0.0144	CcSEcCtD
Zuclopenthixol—Jaundice—Ramipril—type 1 diabetes mellitus	0.0054	0.0138	CcSEcCtD
Zuclopenthixol—Sweating—Ramipril—type 1 diabetes mellitus	0.00531	0.0136	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.00523	0.0134	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.00517	0.0132	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00489	0.0125	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00488	0.0125	CcSEcCtD
Zuclopenthixol—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00479	0.0122	CcSEcCtD
Zuclopenthixol—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00463	0.0118	CcSEcCtD
Zuclopenthixol—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00449	0.0115	CcSEcCtD
Zuclopenthixol—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00444	0.0113	CcSEcCtD
Zuclopenthixol—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00435	0.0111	CcSEcCtD
Zuclopenthixol—Erythema—Ramipril—type 1 diabetes mellitus	0.00433	0.011	CcSEcCtD
Zuclopenthixol—Malnutrition—Ramipril—type 1 diabetes mellitus	0.00433	0.011	CcSEcCtD
Zuclopenthixol—Tension—Ramipril—type 1 diabetes mellitus	0.00424	0.0108	CcSEcCtD
Zuclopenthixol—Nervousness—Ramipril—type 1 diabetes mellitus	0.0042	0.0107	CcSEcCtD
Zuclopenthixol—Tremor—Ramipril—type 1 diabetes mellitus	0.00405	0.0104	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00401	0.0103	CcSEcCtD
Zuclopenthixol—Agitation—Ramipril—type 1 diabetes mellitus	0.00397	0.0102	CcSEcCtD
Zuclopenthixol—DRD2—retina—type 1 diabetes mellitus	0.00395	0.0334	CbGeAlD
Zuclopenthixol—Malaise—Ramipril—type 1 diabetes mellitus	0.0039	0.00996	CcSEcCtD
Zuclopenthixol—Vertigo—Ramipril—type 1 diabetes mellitus	0.00389	0.00993	CcSEcCtD
Zuclopenthixol—Syncope—Ramipril—type 1 diabetes mellitus	0.00388	0.00991	CcSEcCtD
Zuclopenthixol—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00387	0.00989	CcSEcCtD
Zuclopenthixol—Palpitations—Ramipril—type 1 diabetes mellitus	0.00382	0.00976	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.0038	0.00971	CcSEcCtD
Zuclopenthixol—Convulsion—Ramipril—type 1 diabetes mellitus	0.00375	0.00957	CcSEcCtD
Zuclopenthixol—Myalgia—Ramipril—type 1 diabetes mellitus	0.00368	0.00941	CcSEcCtD
Zuclopenthixol—Anxiety—Ramipril—type 1 diabetes mellitus	0.00367	0.00937	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00366	0.00934	CcSEcCtD
Zuclopenthixol—Discomfort—Ramipril—type 1 diabetes mellitus	0.00364	0.00929	CcSEcCtD
Zuclopenthixol—Dry mouth—Ramipril—type 1 diabetes mellitus	0.0036	0.0092	CcSEcCtD
Zuclopenthixol—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00359	0.0303	CbGeAlD
Zuclopenthixol—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00353	0.00902	CcSEcCtD
Zuclopenthixol—Shock—Ramipril—type 1 diabetes mellitus	0.00347	0.00887	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00346	0.00884	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00346	0.00883	CcSEcCtD
Zuclopenthixol—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00345	0.0088	CcSEcCtD
Zuclopenthixol—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00343	0.00876	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00341	0.00872	CcSEcCtD
Zuclopenthixol—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.00341	0.0288	CbGeAlD
Zuclopenthixol—Anorexia—Ramipril—type 1 diabetes mellitus	0.00336	0.00859	CcSEcCtD
Zuclopenthixol—Hypotension—Ramipril—type 1 diabetes mellitus	0.0033	0.00843	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00322	0.00821	CcSEcCtD
Zuclopenthixol—Insomnia—Ramipril—type 1 diabetes mellitus	0.00319	0.00816	CcSEcCtD
Zuclopenthixol—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00317	0.0081	CcSEcCtD
Zuclopenthixol—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.00316	0.128	CrCbGaD
Zuclopenthixol—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00315	0.00804	CcSEcCtD
Zuclopenthixol—Somnolence—Ramipril—type 1 diabetes mellitus	0.00314	0.00802	CcSEcCtD
Zuclopenthixol—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00311	0.00794	CcSEcCtD
Zuclopenthixol—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00307	0.00784	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00305	0.00778	CcSEcCtD
Zuclopenthixol—Fatigue—Ramipril—type 1 diabetes mellitus	0.00304	0.00777	CcSEcCtD
Zuclopenthixol—Constipation—Ramipril—type 1 diabetes mellitus	0.00302	0.00771	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00291	0.00743	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00289	0.00737	CcSEcCtD
Zuclopenthixol—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.00287	0.0242	CbGeAlD
Zuclopenthixol—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00279	0.00713	CcSEcCtD
Zuclopenthixol—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00279	0.00713	CcSEcCtD
Zuclopenthixol—HTR2A—retina—type 1 diabetes mellitus	0.00261	0.022	CbGeAlD
Zuclopenthixol—Chlorprothixene—CHRM2—type 1 diabetes mellitus	0.0026	0.106	CrCbGaD
Zuclopenthixol—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.0026	0.00664	CcSEcCtD
Zuclopenthixol—Asthenia—Ramipril—type 1 diabetes mellitus	0.00253	0.00647	CcSEcCtD
Zuclopenthixol—ADRA2A—pancreas—type 1 diabetes mellitus	0.00252	0.0213	CbGeAlD
Zuclopenthixol—Pruritus—Ramipril—type 1 diabetes mellitus	0.0025	0.00638	CcSEcCtD
Zuclopenthixol—Thioridazine—CHRM2—type 1 diabetes mellitus	0.00246	0.0999	CrCbGaD
Zuclopenthixol—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00242	0.00617	CcSEcCtD
Zuclopenthixol—Dizziness—Ramipril—type 1 diabetes mellitus	0.00233	0.00596	CcSEcCtD
Zuclopenthixol—Trifluoperazine—CHRM2—type 1 diabetes mellitus	0.00228	0.0927	CrCbGaD
Zuclopenthixol—Loxapine—CHRM2—type 1 diabetes mellitus	0.00227	0.0921	CrCbGaD
Zuclopenthixol—Vomiting—Ramipril—type 1 diabetes mellitus	0.00224	0.00573	CcSEcCtD
Zuclopenthixol—Rash—Ramipril—type 1 diabetes mellitus	0.00223	0.00569	CcSEcCtD
Zuclopenthixol—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00222	0.00568	CcSEcCtD
Zuclopenthixol—Quetiapine—CHRM2—type 1 diabetes mellitus	0.00222	0.0899	CrCbGaD
Zuclopenthixol—Headache—Ramipril—type 1 diabetes mellitus	0.00221	0.00565	CcSEcCtD
Zuclopenthixol—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00221	0.0186	CbGeAlD
Zuclopenthixol—HTR2A—kidney—type 1 diabetes mellitus	0.00216	0.0182	CbGeAlD
Zuclopenthixol—Nausea—Ramipril—type 1 diabetes mellitus	0.0021	0.00536	CcSEcCtD
Zuclopenthixol—CYP2D6—kidney—type 1 diabetes mellitus	0.00197	0.0166	CbGeAlD
Zuclopenthixol—Loxapine—ADRB1—type 1 diabetes mellitus	0.00194	0.0785	CrCbGaD
Zuclopenthixol—Clozapine—CHRM2—type 1 diabetes mellitus	0.00191	0.0773	CrCbGaD
Zuclopenthixol—Chlorpromazine—CHRM2—type 1 diabetes mellitus	0.00179	0.0727	CrCbGaD
Zuclopenthixol—Thioproperazine—ALB—type 1 diabetes mellitus	0.00115	0.0467	CrCbGaD
Zuclopenthixol—Pipotiazine—ALB—type 1 diabetes mellitus	0.00113	0.0459	CrCbGaD
Zuclopenthixol—Thiothixene—ALB—type 1 diabetes mellitus	0.00113	0.0459	CrCbGaD
Zuclopenthixol—Chlorpromazine—ALB—type 1 diabetes mellitus	0.000614	0.0249	CrCbGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000147	0.000316	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000146	0.000315	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000146	0.000315	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000146	0.000314	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000145	0.000311	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000145	0.00031	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000144	0.00031	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000144	0.00031	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000143	0.000308	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000142	0.000306	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000142	0.000306	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000142	0.000305	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000142	0.000305	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	0.000142	0.000305	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000141	0.000304	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00014	0.000301	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000139	0.0003	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000139	0.000299	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000139	0.000299	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000139	0.000298	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000138	0.000296	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000138	0.000296	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000137	0.000294	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000137	0.000294	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000137	0.000294	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000137	0.000294	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000137	0.000294	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000135	0.00029	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000135	0.00029	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000135	0.000289	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000134	0.000288	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000134	0.000288	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000133	0.000287	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000133	0.000286	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000131	0.000282	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000131	0.000282	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000131	0.000282	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000131	0.000281	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000131	0.000281	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.00013	0.000279	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00013	0.000278	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000129	0.000278	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000129	0.000278	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000129	0.000277	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000128	0.000276	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000127	0.000272	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000125	0.000269	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000125	0.000268	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000125	0.000268	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000123	0.000265	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000123	0.000264	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000123	0.000264	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SST—type 1 diabetes mellitus	0.000122	0.000263	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000122	0.000263	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—INS—type 1 diabetes mellitus	0.000122	0.000262	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000122	0.000262	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000121	0.00026	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00012	0.000258	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	0.00012	0.000258	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SST—type 1 diabetes mellitus	0.00012	0.000258	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00012	0.000257	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00012	0.000257	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000119	0.000257	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000119	0.000257	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000119	0.000255	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000118	0.000254	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000118	0.000253	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000118	0.000253	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000118	0.000253	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000117	0.000252	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000117	0.000252	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	0.000117	0.000251	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000112	0.000241	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000112	0.00024	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000109	0.000235	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000109	0.000234	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000109	0.000234	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000109	0.000234	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000107	0.00023	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000107	0.00023	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000107	0.00023	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000106	0.000228	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000105	0.000226	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000105	0.000225	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000104	0.000224	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	0.000104	0.000223	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000103	0.000222	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000103	0.000221	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000103	0.000221	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000102	0.000219	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000102	0.000219	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000102	0.000218	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000101	0.000217	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.0001	0.000215	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.0001	0.000215	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.0001	0.000215	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.97e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CD80—type 1 diabetes mellitus	9.97e-05	0.000214	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	9.88e-05	0.000212	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.82e-05	0.000211	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.79e-05	0.00021	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	9.78e-05	0.00021	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	9.76e-05	0.00021	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	9.71e-05	0.000209	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	9.54e-05	0.000205	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—INS—type 1 diabetes mellitus	9.42e-05	0.000202	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.39e-05	0.000202	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.26e-05	0.000199	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.22e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	9.12e-05	0.000196	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IGF1—type 1 diabetes mellitus	9.11e-05	0.000196	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.11e-05	0.000196	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.09e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.09e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.09e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.08e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—type 1 diabetes mellitus	9.07e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—EGFR—type 1 diabetes mellitus	9.07e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.06e-05	0.000195	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.03e-05	0.000194	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.92e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.89e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	8.88e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	8.74e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CD86—type 1 diabetes mellitus	8.72e-05	0.000187	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CD80—type 1 diabetes mellitus	8.58e-05	0.000184	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	8.56e-05	0.000184	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.49e-05	0.000182	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.43e-05	0.000181	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.42e-05	0.000181	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.35e-05	0.000179	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.33e-05	0.000179	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.29e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.29e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.28e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NOS3—type 1 diabetes mellitus	8.26e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.26e-05	0.000177	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.18e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.12e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—INS—type 1 diabetes mellitus	8.11e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.01e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	7.95e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.88e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.88e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.87e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.84e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.81e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.76e-05	0.000167	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.75e-05	0.000167	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.74e-05	0.000166	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.72e-05	0.000166	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.71e-05	0.000166	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.64e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.64e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.62e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	7.6e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.6e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.59e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.58e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.57e-05	0.000163	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.55e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.48e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.42e-05	0.00016	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.25e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.17e-05	0.000154	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.11e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.05e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.01e-05	0.000151	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	7e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.97e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.95e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.94e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.9e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	6.56e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.48e-05	0.000139	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	6.44e-05	0.000138	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.38e-05	0.000137	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.36e-05	0.000137	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.24e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	6.12e-05	0.000132	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.04e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.03e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	6.03e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	6.01e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	6.01e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.92e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.9e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.89e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.89e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.83e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.82e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.8e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.8e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.79e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	5.75e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.71e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.68e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	5.48e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.47e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.38e-05	0.000116	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.37e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.37e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.36e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	5.33e-05	0.000115	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.3e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.28e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.28e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.27e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.27e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.17e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.07e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.9e-05	0.000105	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.81e-05	0.000103	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.61e-05	9.91e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.56e-05	9.79e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.55e-05	9.78e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.53e-05	9.73e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.49e-05	9.64e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.48e-05	9.62e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.48e-05	9.62e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.47e-05	9.6e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.46e-05	9.58e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.45e-05	9.55e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.39e-05	9.44e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.39e-05	9.42e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.36e-05	9.38e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	4.27e-05	9.18e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	4.12e-05	8.85e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.08e-05	8.77e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.07e-05	8.75e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.05e-05	8.71e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.92e-05	8.41e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.83e-05	8.23e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.77e-05	8.1e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.76e-05	8.08e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.75e-05	8.05e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.69e-05	7.93e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.54e-05	7.61e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.48e-05	7.48e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.43e-05	7.37e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.43e-05	7.36e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.42e-05	7.34e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.35e-05	7.21e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.12e-05	6.7e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.68e-05	5.75e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.63e-05	5.66e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.63e-05	5.64e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.58e-05	5.54e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.4e-05	5.15e-05	CbGpPWpGaD
